Civic Intelligence

Alfred E Mann Foundation for Scientific Research

990 • Fiscal year 2018 • EIN 95-4002032

Apr 01, 2017 to Mar 31, 2018 • Filed on Jul 30, 2018

Organization ProfileWWW.AEMF.ORG

View Organization Page

25134 Rye Canyon LoopSanta Clarita, CA 91355

(661) 702-6700

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

10th percentile

0.01x

Higher debt load relative to assets than 10% of similar nonprofits.

2018 filings • 501(c)3 • $50M-$100M nonprofits • Source year 2018

Liabilities / Revenue

81st percentile

1.52x

Higher debt load relative to revenue than 81% of similar nonprofits.

2018 filings • 501(c)3 • $50M-$100M nonprofits • Source year 2018

Net Margin

1st percentile

-2931%

Higher net margin than 1% of similar nonprofits.

2018 filings • 501(c)3 • $50M-$100M nonprofits • Source year 2018

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2018

Asset Growth

2nd percentile

-21%

Faster asset growth than 2% of similar nonprofits.

2018 filings • 501(c)3 • $50M-$100M nonprofits • Annualized from 2017 to 2018

Revenue Growth

3rd percentile

-56%

Faster revenue growth than 3% of similar nonprofits.

2018 filings • 501(c)3 • $50M-$100M nonprofits • Annualized from 2017 to 2018

Balance Sheet
Liabilities / Assets10th percentile

Assets

Down

$50,020,916

Down $13,501,516 (-21%) from 2017

Net Assets

Down

$49,364,115

Down $12,506,436 (-20%) from 2017

Liabilities

Down

$656,801

Down $995,080 (-60%) from 2017

Revenue And Expenses
Liabilities / Revenue81st percentileNet Margin1st percentile

Revenue

Down

$431,624

Down $555,053 (-56%) from 2017

Expenses

Down

$13,081,377

Down $2,264,530 (-15%) from 2017

Net Income

Up

-$12,649,753

Up $1,709,477 (+12%) from 2017

Historical Trend

Balance Sheet Trend

Asset Growth2nd percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$400M$300M$200M$100M$0Assets 2011: $149,147,272Liabilities 2011: $15,477,095Net Assets 2011: $133,670,1772011Assets 2012: $127,153,690Liabilities 2012: $14,940,475Net Assets 2012: $112,213,2152012Assets 2013: $121,867,281Liabilities 2013: $15,413,443Net Assets 2013: $106,453,8382013Assets 2014: $114,740,000Liabilities 2014: $11,197,787Net Assets 2014: $103,542,2132014Assets 2015: $108,633,540Liabilities 2015: $15,219,334Net Assets 2015: $93,414,2062015Assets 2016: $82,113,434Liabilities 2016: $8,156,995Net Assets 2016: $73,956,4392016Assets 2017: $63,522,432Liabilities 2017: $1,651,881Net Assets 2017: $61,870,5512017Assets 2018: $50,020,916Liabilities 2018: $656,801Net Assets 2018: $49,364,1152018Assets 2019: $93,529,351Liabilities 2019: $7,095,338Net Assets 2019: $86,434,0132019Assets 2020: $59,071,014Liabilities 2020: $11,490,776Net Assets 2020: $47,580,2382020Assets 2021: $307,411,437Liabilities 2021: $2,731,424Net Assets 2021: $304,680,0132021Assets 2022: $374,343,975Liabilities 2022: $2,647,791Net Assets 2022: $371,696,1842022Assets 2023: $344,680,217Liabilities 2023: $5,996,723Net Assets 2023: $338,683,4942023Assets 2024: $372,537,856Liabilities 2024: $6,669,955Net Assets 2024: $365,867,9012024Assets 2025: $353,361,768Liabilities 2025: $6,385,007Net Assets 2025: $346,976,7612025

Highlighted filing

2018

Assets$50,020,916
Liabilities$656,801
Net Assets$49,364,115
Open 2018 Filing

Operations Trend

Revenue Growth3rd percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$300M$200M$100M$0-$100MExpenses 2011: $21,995,3702011Expenses 2012: $24,699,7402012Expenses 2013: $22,317,5392013Revenue 2014: $19,639,842Expenses 2014: $24,203,179Net Income 2014: -$4,563,3372014Revenue 2015: $7,594,704Expenses 2015: $17,902,645Net Income 2015: -$10,307,9412015Revenue 2016: $4,540,535Expenses 2016: $17,253,210Net Income 2016: -$12,712,6752016Revenue 2017: $986,677Expenses 2017: $15,345,907Net Income 2017: -$14,359,2302017Revenue 2018: $431,624Expenses 2018: $13,081,377Net Income 2018: -$12,649,7532018Revenue 2019: $334,706Expenses 2019: $8,041,139Net Income 2019: -$7,706,4332019Revenue 2020: $2,312,474Expenses 2020: $13,859,108Net Income 2020: -$11,546,6342020Revenue 2021: $225,963,433Expenses 2021: $22,418,205Net Income 2021: $203,545,2282021Revenue 2022: $128,538,828Expenses 2022: $18,142,697Net Income 2022: $110,396,1312022Revenue 2023: $31,054,042Expenses 2023: $22,822,234Net Income 2023: $8,231,8082023Revenue 2024: $44,147,259Expenses 2024: $31,844,936Net Income 2024: $12,302,3232024Revenue 2025: $18,144,382Expenses 2025: $41,776,524Net Income 2025: -$23,632,1422025

Highlighted filing

2018

Revenue$431,624
Expenses$13,081,377
Net Income-$12,649,753
Open 2018 Filing
Jump To
Filing Snapshot
Filing Period
Apr 1, 2017 to Mar 31, 2018
Signed
Jul 30, 2018
Return Version
2017v2.3
Gross Receipts
$17,519,425
Mission and Program Overview

Mission

The alfred mann foundation is a medical research organization dedicated to bringing advanced medical technologies to the public to provide significant improvements to the health, security and quality of life for people suffering from debilitating medical conditions.

Conduct medical and scientific research

Balance Sheet Detail
LineBeginningEndChange
Assets
Investments Other Securities$38,540,950$43,217,152▲ $4,676,202
Investments in Publicly Traded Securities$18,340,481$1,680,063▼ $16,660,418
Land, Buildings, and Equipment, Net$1,533,953$1,219,299▼ $314,654
Savings and Temporary Cash Investments$1,342,188$1,087,587▼ $254,601
Intangible Assets$694,046$907,711▲ $213,665
Cash and Non-Interest-Bearing Accounts$1,392,667$434,791▼ $957,876
Prepaid Expenses and Deferred Charges$397,189$252,469▼ $144,720
Accounts Receivable$68,319$2,824▼ $65,495
Total Assets$63,522,432$50,020,916▼ $13,501,516
Other Assets Total$1,212,639$1,219,020▲ $6,381
Liabilities
Accounts Payable and Accrued Expenses$1,651,881$656,801▼ $995,080
Total Liabilities$1,651,881$656,801▼ $995,080
Net Assets / Fund Balance
Unrestricted Net Assets$61,870,551$49,364,115▼ $12,506,436
Total Net Assets Fund Balance$61,870,551$49,364,115▼ $12,506,436
Total Liabilities and Net Assets / Fund Balance$63,522,432$50,020,916▼ $13,501,516

Asset Categories

AssetBook ValueDepreciationBasis
Equipment$335,932$4,725,161$5,061,093
Other Land Buildings$33,690$2,076,949$2,110,639
Leasehold Improvements$849,677$709,303$1,558,980
Other Securities$5,552,360--
Compensation and Service Providers
Top Officer PayScore unavailable

Employees

NameTitleFull / Part TimeBaseOtherTotal
David HankinCEO (through 7/10/17)FT$208,800$157,195$365,995
Mark ChamberlainCOOFT$281,151$35,466$316,617
John PetrovichSVP Bus Dev & Gen Coun/CEO (7/10/17)FT$266,827$23,468$290,295
Glen GriffithTechnical DirectorFT$201,643$60,341$261,984
Edward LeeSenior Asic Design EngineerFT$172,214$87,678$259,892
Farah BoroomandCFOFT$224,481$28,149$252,630
James WolfePrincipal Asic Design EngineerFT$169,721$78,584$248,305
Brian DeardenDirector, Electrical EngineeringFT$160,687$39,294$199,981
Michael PerrinVP, Quality, Regulatory, ClinicalFT$166,306$29,827$196,133
Grigor GolamiriansDirector, Manufacturing EngineeringFT$160,867$35,205$196,072
Valma KleinDirector, Clinical ResearchFT$159,350$35,018$194,368
Joseph CalderonProgram DirectorFT$149,922$39,285$189,207
Siegmar SchmidtEmerging Technologies Group MgrFT$160,200$27,406$187,606

Board Members and Trustees

NameTitle
Robert GreenbergChairman
Mari DanihelBoard Member
Richard WaughBoard Member

Highest Paid Contractors

ContractorServicesLocationCompensation
Morgan LewisLegal300 SOUTH GRAND AVENUE 22ND FLOOR, Los Angeles, CA 90071-3132$960,156
Vista Ip Law Group LLPPatent100 SPECTRUM CENTER DRIVE SUITE 90, Irvine, CA 92618$117,361
Revenue and Support

Revenue Composition

Contributions and Grants
$86,184
Program Service Revenue
$0
Investment Income
$313,818
Other Revenue
$31,622
All Other Contributions
$86,184
Change in Net Assets
$-12,649,753
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Salaries, Compensation, and Employee Benefits$9,144,662
Other Expenses$3,931,715
Grants and Similar Amounts Paid$5,000
Total Fundraising Expense$821
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Other Salaries and Wages$5,181,268$663,451-$5,844,719
Current Officers, Directors, Trustees, and Key Employees$1,511,048$637,647-$2,148,695
Fees for Services Legal$882,972$255,155-$1,138,127
Occupancy$810,723$162,710-$973,433
Other Employee Benefits$452,695$76,741-$529,436
Payroll Taxes$432,031$95,319-$527,350
Office Expenses$454,971$42,336$821$498,128
Depreciation Depletion$302,574$124,354-$426,928
Fees for Services Other$334,858$35,820-$370,678
Information Technology$201,945$52,552-$254,497
Insurance$80,762$16,229-$96,991
Pension Plan Contributions$77,388$17,074-$94,462
Fees for Services Accounting-$87,893-$87,893
Travel$29,388$8,741-$38,129
Other Expenses$4,223$4,316-$8,539
Conferences and Meetings$3,331$2,826-$6,157
Fees for Service Investment Mgmnt Fees-$5,393-$5,393
Grants to Domestic Orgs$5,000--$5,000
Total Functional Expenses$10,788,414$2,292,142$821$13,081,377
International Activity

International Summary

Offices
0
Employees
0
Spending
$920,930

International Compliance

Activity in boycott countries
No
Foreign corporation ownership
Yes
Foreign partnership interest
Yes
Interest in foreign trust
No
Passive foreign investment company interest
Yes
Transfers to foreign corporations
Yes

International Activities

RegionActivityServicesOfficesEmployeesSpending
Central America and the CaribbeanInvestments-00$918,717
Central America and the CaribbeanInvestment Fee Expenditures-00$2,213
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
Yes
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section A, Line 6

“The foundation's articles of incorporation provide that the foundation is a membership corporation, with the members having the rights of membership as described in the foundation's bylaws. The bylaws provided for the foundation to have a lead member, designated by the bylaws to be alfred e. Mann, who would possess all powers of membership conferred by law. The bylaws also provided that up to four additional members, appointed by the lead member, would have only those rights conferred upon them by the bylaws, which include only the right to name a successor lead member under certain described circumstances. After al mann's passing, the trustees of his living trust were designated to share the "lead member" role in the foundation, having the legal ability to name and remove members of the board of directors of the foundation. In the fiscal year ending 3/31/18, the trustees notified the foundation that they were not going to be active in the role of the lead member, would like to resign from the position, and intended to approve amendments to the articles of incorporation and bylaws of the foundation that would make the foundation a nonmembership nonprofit, where the board of directors has the power to name and remove members of the board, making the board self-perpetuating. The articles of incorporation and bylaws were amended to make these changes in may 2018, but the required documents were in negotiation as of fye 3/31/18.”

Form 990, Part VI, Section A, Line 7A

“The foundation's bylaws provide that the foundation shall have one lead member who has the power to appoint, remove, and name successors for all members of the board of directors of the foundation. After al mann's passing, the trustees of his living trust were designated to share the "lead member" role in the foundation, having the legal ability to name and remove members of the board of directors of the foundation. In the fiscal year ending 3/31/18, the trustees notified the foundation that they were not going to be active in the role of the lead member, would like to resign from the position, and intended to approve amendments to the articles of incorporation and bylaws of the foundation that would make the foundation a nonmembership nonprofit, where the board of directors has the power to name and remove members of the board, making the board self-perpetuating. The articles of incorporation and bylaws were amended to make these changes in may 2018, but the required documents were in negotiation as of fye 3/31/18.”

Form 990, Part VI, Section B, Line 11B

“A draft of form 990 was presented by management to the audit committee of the board of directors for their review and discussion. A full copy of the form was provided to all voting members prior to filing with the irs.”

Form 990, Part VI, Section B, Line 12C

“Conflict of interest disclosures are updated annually and potential conflicts are reviewed prior to participating in transactions. If a conflict exists, the person with a conflict does not vote.”

Form 990, Part VI, Section B, Line 15

“The board of directors reviews and approves the compensation of the ceo and his direct reports including the cfo. They also review and approve the overall annual adjustments to compensation of other employees. Specific adjustments for other employees are handled by the ceo and head of human resources using comparisons to salary surveys for similar positions and experience. The board of directors approved compensation for the ceo and his direct reports including the cfo on 04/03/18. This process was documented.”

Form 990, Part VI, Section C, Line 19

“Members of the public or interested parties may request to review or recieve a copy of the governing documents, conflict of interest policy, and financial statements by phone or mail.”

Filing and Contact Details

Filer

Filer Name
Alfred E Mann Foundation for
EIN
95-4002032
Phone
6617026700
Address
25134 RYE CANYON LOOP, SANTA CLARITA, CA 91355

Signing Officer

Name
John Petrovich
Title
CEO
Phone
6617026700
Signed
2018-07-30
Discuss with paid preparer
Yes

Organization Details

Principal Officer
John Petrovich
Formed
1985
Legal Domicile
CA
Voting Board Members
3
Independent Board Members
3
Employees
71
Volunteers
0

Preparer

Firm
Moss Adams Llp
Address
10960 WILSHIRE BLVD SUITE 1100, LOS ANGELES, CA 90024
Preparer
Lauren a Haverlock
Phone
3104770450
Supplemental Narrative

Financial Statement Notes

PART X, LINE 2:

“The alfred e. Mann foundation for scientific research is exempt from federal income and california franchise taxes under section 501(c)(3) of the internal revenue code and the corresponding california provisions. The foundation's subsidiaries are c corporations and are subject to federal income and california franchise taxes. The alfred e. Mann foundation for scientific research had no significant unrelated business income tax during the years ended march 31, 2018 and 2017. Accordingly, no tax provision for unrelated business income has been made in the accompanying consolidated financial statements for the years ended march 31, 2018 and 2017. Medallion therapeutics, inc. And monolythix, inc. Are for-profit entities. Income taxes for these entities are provided for under the liability method, and as such, deferred income taxes are recognized for the tax consequences of temporary differences by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts and the tax basis of existing assets and liabilities. A valuation allowance reduces deferred income tax assets when it is more likely than not that some portion or all of the deferred income tax assets will not be realized. The temporary differences consisted primarily of net operating loss carry forwards, which expire on various dates through 2026. At march 31, 2018 and 2017, monolythix, a subsidiary of the foundation, had recorded a valuation allowance of $661,000 against the full value of its deferred tax assets. At march 31, 2018 and 2017, medallion, a subsidiary of the foundation, had no deferred tax assets. The foundation, under the provisions of asc 740, income taxes, had no uncertain tax positions requiring accrual as of march 31, 2018 and 2017.”

Raw XML AppendixShowing 400 of 834 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt01651881
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt0656801
IRS990/AccountsReceivableGrp/BOYAmt068319
IRS990/AccountsReceivableGrp/EOYAmt02824
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0CONDUCT MEDICAL AND SCIENTIFIC RESEARCH
IRS990/AllOtherContributionsAmt086184
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0RENEE OLIVIERI
IRS990/BooksInCareOfDetail/PhoneNum06617026883
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt025134 RYE CANYON LOOP
IRS990/BooksInCareOfDetail/USAddress/CityNm0SANTA CLARITA
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd091355
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOfficerEntInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt01392667
IRS990/CashNonInterestBearingGrp/EOYAmt0434791
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt02
IRS990/CollectionsOfArtInd00
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt0637647
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt01511048
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt02148695
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd01
IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt02826
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt03331
IRS990/ConferencesMeetingsGrp/TotalAmt06157
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd01
IRS990/ContractorCompensationGrp/CompensationAmt0960156
IRS990/ContractorCompensationGrp/CompensationAmt1117361
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt0300 SOUTH GRAND AVENUE 22ND FLOOR
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt1100 SPECTRUM CENTER DRIVE SUITE 90
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm0LOS ANGELES
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm1IRVINE
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd0CA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd1CA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd0900713132
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd192618
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt0MORGAN LEWIS
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt1VISTA IP LAW GROUP LLP
IRS990/ContractorCompensationGrp/ServicesDesc0LEGAL
IRS990/ContractorCompensationGrp/ServicesDesc1PATENT
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt086184
IRS990/CYGrantsAndSimilarPaidAmt05000
IRS990/CYInvestmentIncomeAmt0313818
IRS990/CYOtherExpensesAmt03931715
IRS990/CYOtherRevenueAmt031622
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0-12649753
IRS990/CYSalariesCompEmpBnftPaidAmt09144662
IRS990/CYTotalExpensesAmt013081377
IRS990/CYTotalFundraisingExpenseAmt0821
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt0431624
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt0124354
IRS990/DepreciationDepletionGrp/ProgramServicesAmt0302574
IRS990/DepreciationDepletionGrp/TotalAmt0426928
IRS990/Desc0IMPLANTABLE MYOELECTRIC SENSOR II (INFINITY)THE INITIAL IMES COLLABORATION WAS RE-VITALIZED TO COMMENCE RESEARCH AND DEVELOPMENT WORK ON A SECOND GENERATION OF IMES, WHICH WILL CONTAIN ADVANCED FEATURES BASED ON PATIENT FEEDBACK RECEIVED FORM THE IMES I CLINICAL TRIAL. THESE FEATURES ARE INTENDED TO IMPROVE MEDICAL OUTCOMES AT NO ADDITIONAL COST TO THE PATIENT OR HEALTHCARE SYSTEM. THIS WAS PARTIALLY SUPPORTED BY A GRANT FROM THE NATIONAL INSTITUTES OF HEALTH. STATUS: THE FINAL TESTING OF THE IMES-INFINITY SYSTEM WAS COMPLETED DURING THE LAST YEAR. THIS TESTING INCLUDED FULL ELECTRICAL, MECHANICAL, SOFTWARE, SYSTEM INTEGRATION, PRE-CLINICAL, AND SAFETY TESTING. ALL TESTING WAS COMPLETED AND PASSED PER THE APPLICABLE REGULATIONS AND STANDARDS.AMF VETTED MULTIPLE COMPANIES FOR POTENTIAL COMMERCIALIZATION OF THE IMES-INFINITY SYSTEM. WE HAVE NARROWED THE FIELD DOWN TO ONE COMPANY THAT WE BELIEVE CAN SUCCESSFULLY COMMERCIALIZE THIS SYSTEM AND GET IT OUT TO THE PATIENTS WHO NEED IT. NEGOTIATIONS ARE CURRENTLY UNDER WAY. WE ANTICIPATE A CONTRACT WILL BE IN PLACE WITHIN THE NEXT FEW MONTHS.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/ElectionOfBoardMembersInd01
IRS990/EmployeeCnt071
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt05259870
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt087893
IRS990/FeesForServicesAccountingGrp/TotalAmt087893
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt0255155
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt0882972
IRS990/FeesForServicesLegalGrp/TotalAmt01138127
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt035820
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt0334858
IRS990/FeesForServicesOtherGrp/TotalAmt0370678
IRS990/FeesForSrvcInvstMgmntFeesGrp/ManagementAndGeneralAmt05393
IRS990/FeesForSrvcInvstMgmntFeesGrp/TotalAmt05393
IRS990/ForeignActivitiesInd01
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt02.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt12.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt22.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt355.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt465.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt563.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt660.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt748.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt844.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt944.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1042.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1140.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1240.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1340.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1440.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1540.00
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd2X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd3X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd2X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd3X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd3X
IRS990/Form990PartVIISectionAGrp/OfficerInd4X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt330937
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt423468
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt528149
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt635466
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt718827
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt820065
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt921454
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1019805
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1121596
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1220462
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1326529
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1419818
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1515492
IRS990/Form990PartVIISectionAGrp/PersonNm0ROBERT GREENBERG
IRS990/Form990PartVIISectionAGrp/PersonNm1RICHARD WAUGH
IRS990/Form990PartVIISectionAGrp/PersonNm2MARI DANIHEL
IRS990/Form990PartVIISectionAGrp/PersonNm3DAVID HANKIN
IRS990/Form990PartVIISectionAGrp/PersonNm4JOHN PETROVICH
IRS990/Form990PartVIISectionAGrp/PersonNm5FARAH BOROOMAND
IRS990/Form990PartVIISectionAGrp/PersonNm6MARK CHAMBERLAIN
IRS990/Form990PartVIISectionAGrp/PersonNm7MICHAEL PERRIN
IRS990/Form990PartVIISectionAGrp/PersonNm8JOSEPH CALDERON
IRS990/Form990PartVIISectionAGrp/PersonNm9BRIAN DEARDEN
IRS990/Form990PartVIISectionAGrp/PersonNm10GRIGOR GOLAMIRIANS
IRS990/Form990PartVIISectionAGrp/PersonNm11EDWARD LEE
IRS990/Form990PartVIISectionAGrp/PersonNm12GLEN GRIFFITH
IRS990/Form990PartVIISectionAGrp/PersonNm13JAMES WOLFE
IRS990/Form990PartVIISectionAGrp/PersonNm14VALMA KLEIN
IRS990/Form990PartVIISectionAGrp/PersonNm15SIEGMAR SCHMIDT
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt3335058
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt4266827
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt5224481
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt6281151
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt7177306
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt8169142
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt9178527
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10176267
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt11238296
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt12241522
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt13221776
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt14174550
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt15172114
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt130
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt140
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt150
IRS990/Form990PartVIISectionAGrp/TitleTxt0CHAIRMAN
IRS990/Form990PartVIISectionAGrp/TitleTxt1BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt2BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt3CEO (THROUGH 7/10/17)
IRS990/Form990PartVIISectionAGrp/TitleTxt4SVP BUS DEV & GEN COUN/CEO (7/10/17)
IRS990/Form990PartVIISectionAGrp/TitleTxt5CFO
IRS990/Form990PartVIISectionAGrp/TitleTxt6COO
IRS990/Form990PartVIISectionAGrp/TitleTxt7VP, QUALITY, REGULATORY, CLINICAL
IRS990/Form990PartVIISectionAGrp/TitleTxt8PROGRAM DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt9DIRECTOR, ELECTRICAL ENGINEERING
IRS990/Form990PartVIISectionAGrp/TitleTxt10DIRECTOR, MANUFACTURING ENGINEERING
IRS990/Form990PartVIISectionAGrp/TitleTxt11SENIOR ASIC DESIGN ENGINEER
IRS990/Form990PartVIISectionAGrp/TitleTxt12TECHNICAL DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt13PRINCIPAL ASIC DESIGN ENGINEER
IRS990/Form990PartVIISectionAGrp/TitleTxt14DIRECTOR, CLINICAL RESEARCH
IRS990/Form990PartVIISectionAGrp/TitleTxt15EMERGING TECHNOLOGIES GROUP MGR
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/Form990TFiledInd01
IRS990/FormationYr01985
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/ConsolidatedBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/GainOrLossGrp/OtherAmt0-23250
IRS990/GainOrLossGrp/SecuritiesAmt0-22350
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt03
IRS990/GrantAmt05000
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt05000
IRS990/GrantsToDomesticOrgsGrp/TotalAmt05000
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd00
IRS990/GrantToRelatedPersonInd00
IRS990/GrossAmountSalesAssetsGrp/OtherAmt04748
IRS990/GrossAmountSalesAssetsGrp/SecuritiesAmt017037453
IRS990/GrossReceiptsAmt017519425
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd01
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt03
IRS990/IndivRcvdGreaterThan100KCnt041
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt052552
IRS990/InformationTechnologyGrp/ProgramServicesAmt0201945
IRS990/InformationTechnologyGrp/TotalAmt0254497
IRS990/InsuranceGrp/ManagementAndGeneralAmt016229
IRS990/InsuranceGrp/ProgramServicesAmt080762
IRS990/InsuranceGrp/TotalAmt096991
IRS990/IntangibleAssetsGrp/BOYAmt0694046
IRS990/IntangibleAssetsGrp/EOYAmt0907711
IRS990/InvestmentIncomeGrp/ExclusionAmt061608
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt0359418
IRS990/InvestmentIncomeGrp/UnrelatedBusinessRevenueAmt0297810
IRS990/InvestmentInJointVentureInd01
IRS990/InvestmentsOtherSecuritiesGrp/BOYAmt038540950
IRS990/InvestmentsOtherSecuritiesGrp/EOYAmt043217152
IRS990/InvestmentsPubTradedSecGrp/BOYAmt018340481
IRS990/InvestmentsPubTradedSecGrp/EOYAmt01680063
IRS990/IRPDocumentCnt034
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt07511413
IRS990/LandBldgEquipBasisNetGrp/BOYAmt01533953
IRS990/LandBldgEquipBasisNetGrp/EOYAmt01219299
IRS990/LandBldgEquipCostOrOtherBssAmt08730712
IRS990/LegalDomicileStateCd0CA
IRS990/LessCostOthBasisSalesExpnssGrp/OtherAmt027998
IRS990/LessCostOthBasisSalesExpnssGrp/SecuritiesAmt017059803
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd01
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH IS A MEDICAL RESEARCH ORGANIZATION DEDICATED TO DEVELOPING AND COMMERCIALIZING INNOVATIVE SOLUTIONS FOR SIGNIFICANT UNMET MEDICAL CONDITIONS.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NetAssetsOrFundBalancesBOYAmt061870551
IRS990/NetAssetsOrFundBalancesEOYAmt049364115
IRS990/NetGainOrLossInvestmentsGrp/ExclusionAmt0-45600
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt0-45600
IRS990/NetUnrelatedBusTxblIncmAmt0119021
IRS990/NetUnrlzdGainsLossesInvstAmt0143317
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/ManagementAndGeneralAmt0162710
IRS990/OccupancyGrp/ProgramServicesAmt0810723
IRS990/OccupancyGrp/TotalAmt0973433
IRS990/OfficeExpensesGrp/FundraisingAmt0821
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt042336
IRS990/OfficeExpensesGrp/ProgramServicesAmt0454971
IRS990/OfficeExpensesGrp/TotalAmt0498128
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsSFAS117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt01212639
IRS990/OtherAssetsTotalGrp/EOYAmt01219020
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt076741
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt0452695
IRS990/OtherEmployeeBenefitsGrp/TotalAmt0529436
IRS990/OtherExpensesGrp/Desc0EDUCATION & MORALE
IRS990/OtherExpensesGrp/Desc1MISCELLANEOUS
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt03585
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt14316
IRS990/OtherExpensesGrp/ProgramServicesAmt023237
IRS990/OtherExpensesGrp/ProgramServicesAmt14223
IRS990/OtherExpensesGrp/TotalAmt026822
IRS990/OtherExpensesGrp/TotalAmt18539
IRS990/OtherRevenueMiscGrp/BusinessCd0999999
IRS990/OtherRevenueMiscGrp/Desc0OTHER INCOME
IRS990/OtherRevenueMiscGrp/ExclusionAmt07900
IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt07900
IRS990/OtherRevenueTotalAmt07900
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt0663451
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt05181268
IRS990/OtherSalariesAndWagesGrp/TotalAmt05844719
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt095319
IRS990/PayrollTaxesGrp/ProgramServicesAmt0432031
IRS990/PayrollTaxesGrp/TotalAmt0527350
IRS990/PensionPlanContributionsGrp/ManagementAndGeneralAmt017074
IRS990/PensionPlanContributionsGrp/ProgramServicesAmt077388
IRS990/PensionPlanContributionsGrp/TotalAmt094462
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt0397189
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt0252469
IRS990/PrincipalOfficerNm0JOHN PETROVICH
IRS990/ProfessionalFundraisingInd00
IRS990/ProgSrvcAccomActy2Grp/Desc0SLEEP APNEA AMF IS INVESTIGATING THE NEED FOR NEWER METHODS TO TREAT OSA (OBSTRUCTED SLEEP APNEA). OSA IS AN UNDER-DIAGNOSED AND UNDER-TREATED MEDICAL CONDITION THAT HAS BEEN LINKED TO SEVERAL SERIOUS CO-MORBIDITIES, INCLUDING HEART DISEASE. CURRENT TREATMENT OPTIONS ARE POORLY TOLERATED AND WHEN ADOPTED, HAVE LOW COMPLIANCE RATES. THE AIM OF THE AMF PROGRAM IS TO DEVELOP A NEUROSTIMULATION SYSTEM THAT WILL IMPROVE MEDICAL OUTCOMES AT A LOWER COST THAN CURRENTLY AVAILABLE TREATMENT OPTIONS, WHILE SOLVING THE PATIENT COMPLIANCE ISSUE. SUCH A PRODUCT SYSTEM WILL CONSIST OF A FULLY IMPLANTABLE NEURAL STIMULATOR SENSOR, CLOSED LOOP SYSTEM WITH SEAMLESS OPERATION REQUIRING MINIMAL INTERACTION FROM A PATIENT, THEREBY OFFERING A LEVEL OF PATIENT COMPLIANCE AND EFFICACY FAVORABLE TO GOLD STANDARD TREATMENTS. STATUS:SEVERAL POTENTIAL DESIGNS HAVE BEEN TESTED AND REVIEWED, REQUIRING MULTIPLE ENGINEERING, ANIMAL AND CADAVER EXPERIMENTS. THIS PROCESS INCLUDES OBTAINING INPUT FROM KEY OPINION LEADERS; ENT SURGEONS' IMPLANT APPROACHES AND PULMONOLOGISTS TREATING OBSTRUCTIVE SLEEP APNEA. FURTHER TESTING (BOTH BENCH AND ANIMAL) IS IN-PROCESS AND A FINAL DESIGN IS ANTICIPATED BY THE END OF THE FISCAL YEAR.
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt02565609
IRS990/ProgSrvcAccomActy2Grp/GrantAmt00
IRS990/ProgSrvcAccomActy2Grp/RevenueAmt00
IRS990/ProgSrvcAccomActy3Grp/Desc0ADVANCED TECHNOLOGY PROJECTS (NEW PROJECTS) IN THIS GROUP, AMF HAS SEVERAL EARLY STAGE RESEARCH EFFORTS UNDER WAY THAT ARE DIRECTED AT DEVELOPING ADVANCED TECHNOLOGIES AND CONCEPTS. THE TEAM COMPRISES RESEARCH SCIENTISTS, ENGINEERS, LEGAL AND INTELLECTUAL PROPERTY EXPERTS, BUSINESS STRATEGISTS AND ANALYSTS. THIS TEAM MONITORS AND EVALUATES NEW TECHNOLOGIES AND NEW PROJECT IDEAS AND CONCEPTS BEFORE THEY ARE ELEVATED TO THE STATUS OF FULL-FLEDGED DEVELOPMENT PROGRAMS. THE GROUP ALSO PROVIDES BUSINESS PLANNING SUPPORT FOR MORE MATURE AMF PROGRAMS THAT ARE ON THEIR WAY TO BEING COMMERCIALIZED. STATUS:AS THE PROJECTS ARE IN INITIAL FEASIBILITY OR PROOF-OF-CONCEPT STAGE FOR THE MOST PART, EXPENDITURES ON ANY INDIVIDUAL PROJECT ARE LIMITED. SUCCESSFUL PROJECTS ARE SCREENED FOR ELEVATION TO DEVELOPMENT PROGRAM STATUS, OR TO BE FINANCED IN SPINOUT COMPANIES BY THIRD PARTIES. UNSUCCESSFUL EFFORTS ARE TERMINATED. SOME OF THE METRICS REVIEWED FOR PROJECT APPROVAL ARE, PATIENT POPULATION, NEED FOR PRODUCT, MARKET ANALYSIS, REIMBURSEMENT, AND MORE. DURING THE PREVIOUS PERIOD, A NUMBER OF NEW INNOVATIVE PROJECTS HAVE BEEN EVALUATED BY THE TEAM. THESE INCLUDE POTENTIAL PRODUCTS IN THE AREA OF IMPLANTABLE PUMPS, SURFACE IMES, URINARY INCONTINENCE, LOW VISION READING SYSTEM, ACID REFLUX, EPILEPSY PROTECTION SYSTEM, SMART GUNS, RF ID AND MEDICAL SENSOR, MRI COMPATIBILITY, BIOMEDICAL ENERGY HARVESTING, PERSONAL LOCATOR, WEARABLE EXTERNAL ELECTRONIC PATCH, SIDS MONITORING AND ALERT SYSTEM, MOTORIZED DENTAL MOUTH GUARD, SELF-STERILIZING NEEDLE, HYDRO-POWERED ACTIVE FOLEY CATHETER IMPLANT, AND A LEG BLOOD CLOT DETECTOR.
IRS990/ProgSrvcAccomActy3Grp/ExpenseAmt02062629
IRS990/ProgSrvcAccomActy3Grp/GrantAmt00
IRS990/ProgSrvcAccomActy3Grp/RevenueAmt00
IRS990/ProgSrvcAccomActyOtherGrp/Desc0IMPLANTABLE MYOELECTRIC SENSOR (IMES I + CLINICAL) INITIALLY, THE "IMES" PROJECT WAS A CONSORTIUM PROJECT WITH THE FOLLOWING PARTNERS: NORTHWESTERN UNIVERSITY, THE ILLINOIS INSTITUTE OF TECHNOLOGY, AND SIGENICS (A CLOSELY HELD ENGINEERING COMPANY). THE INITIAL FUNDING FOR THE IMES PROGRAM WAS COMING FROM THE NATIONAL INSTITUTES FOR BIOMEDICAL IMAGING AND BIOENGINEERING (NIBIB) AND THE NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT (NICHD), AS WELL AS THE DEFENSE ADVANCED RESEARCH PROJECTS AGENCY (DARPA). IN 2008, AMF ASSUMED CONTROL OF AND RESPONSIBILITY FOR THE ENTIRE PROJECT, PERFORMING MISSION CRITICAL ENGINEERING TASKS, AS WELL AS PREPARING FOR AND CONDUCTING A CLINICAL TRIAL. THE IMES SYSTEM WAS IMPLANTED IN THE RESIDUAL LIMB OF AN AMPUTEE, AND TRANSMITTED MUSCLE SIGNALS TO A WEARABLE PROSTHESIS TO PERMIT CONTROL OF THE PROSTHESIS IN A MORE NATURAL AND INTUITIVE MANNER. STATUS:DURING THE LAST YEAR AMF HAS COUNTINUED TO MONITOR ALL THREE IMES CLINICAL TRIALS. THE FIRST CLINICAL TRIAL IS IN THE US. THIS TRIAL IS FOR TRANSRADIAL (UPPER LIMB, BELOW THE ELBOW) AMPUTATION PATIENTS, AND IS STILL ONGOING AT WALTER REED NATIONAL MILITARY MEDICAL CENTER. THE TWO OTHER CLINICAL TRIALS ARE IN EUROPE. ONE OF THE TRIALS IS IN ICELAND AND THE OTHER IS IN AUSTRIA. THE ICELANDIC STUDY IS FOR A TRANSFEMORAL (LOWER LIMB, ABOVE THE KNEE) AND FOR TRANSTIBIAL (LOWER LIMB, BELOW THE KNEE) AMPUTATION PATIENTS. THE AUSTRIAN STUDY IS FOR TRANSHUMERIAL (UPPER LIMB, ABOVE THE ELBOW) AMPUTATION PATIENTS. PATIENTS FROM ALL THREE TRIALS HAVE REPORTED THAT THE NEW EQUIPMENT MADE AVAILABLE TO THEM HAS IMPROVED THEIR QUALITY OF LIFE. AMF WILL CONTINUE TO MONITOR THE PROGRESS OF THE MULTIPLE PATIENTS ENGAGED IN THESE OPEN CLINICAL TRIALS.
IRS990/ProgSrvcAccomActyOtherGrp/Desc1NEURAL RESPIRATORY DRIVE (NRD)NEURAL RESPIRATORY DRIVE (NRD) CAN BE MONITORED FROM THE AMOUNT OF ELECTRICAL ACTIVITY OCCURRING IN CERTAIN MUSCLES USED FOR BREATHING. ANALYSIS OF ELECTRICAL ACTIVITY AND OTHER MEASUREMENTS (SUCH AS RATE OF BREATHING AND HEART RATE) ALLOWS EARLY DETECTION OF DETERIORATING HEALTH IN PATIENTS WITH BREATHING PROBLEMS AT HOME OR AT THE DOCTOR'S OFFICE. THIS ALLOWS FOR EARLY INTERVENTION, ADDRESSING THE ISSUE SOONER, WHEN IT LESS SEVERE AND REDUCING THE COST OF CARE. CURRENT SYSTEMS ARE INACCURATE, AND REQUIRE CONSIDERABLE, EXPENSIVE RESOURCES. THIS SYSTEM ALLOWS PATIENTS TO IDENTIFY A POTENTIAL ISSUE THEMSELVES, AND SEEK MEDICAL INTERVENTION SOONER, PREVENTING HOSPITALIZATIONS. POTENTIAL PATIENT INCLUDE THOSE WITH COPD, ASTHMA AND PNEUMONIA SUFFERERS.STATUS:THE IMPLANTED MYOELECTRIC SENSOR (IMES) (INFINITY VERSION) WAS COMPLETED DURING FY2017. AMF IS PERFORMING ENGINEERING WORK INCLUDING TESTING TO SEE IF THE IMES CAN BE PART OF A SYSTEM TO ADDRESS THE WEAKNESSES OF CURRENT NRD SYSTEMS. THIS WORK AND TESTING INCLUDES MULTIPLE SYSTEM CONCEPTS, BENCH TESTING, AND PRE-CLINICAL TESTING. A COIL DESIGNED INTERFACE TO THE IMES SENSOR IS UNDER DEVELOPMENT THAT WILL POWER THE SENSOR AND PROVIDES A DATA CONNECTION FOR SIGNAL ANALYSIS AND CALCULATION OF THE NRD INDEX.
IRS990/ProgSrvcAccomActyOtherGrp/ExpenseAmt0831215
IRS990/ProgSrvcAccomActyOtherGrp/ExpenseAmt169091
IRS990/ProgSrvcAccomActyOtherGrp/GrantAmt00
IRS990/ProgSrvcAccomActyOtherGrp/GrantAmt10
IRS990/ProgSrvcAccomActyOtherGrp/RevenueAmt00
IRS990/ProgSrvcAccomActyOtherGrp/RevenueAmt10
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt05865
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt08000
IRS990/PYInvestmentIncomeAmt0953967
IRS990/PYOtherExpensesAmt05741212
IRS990/PYOtherRevenueAmt03000
IRS990/PYProgramServiceRevenueAmt023845
IRS990/PYRevenuesLessExpensesAmt0-14359230
IRS990/PYSalariesCompEmpBnftPaidAmt09596695
IRS990/PYTotalExpensesAmt015345907
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt0986677
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt0-12649753
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd01
IRS990/RelatedOrganizationCtrlEntInd01
IRS990/ReportInvestmentsOtherSecInd01
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd00
IRS990/RevenueAmt00
IRS990/RoyaltiesRevenueGrp/RelatedOrExemptFuncIncomeAmt023722
IRS990/RoyaltiesRevenueGrp/TotalRevenueColumnAmt023722
IRS990/SavingsAndTempCashInvstGrp/BOYAmt01342188
IRS990/SavingsAndTempCashInvstGrp/EOYAmt01087587
IRS990ScheduleA/HospitalNameAndAddressGrp/CityNm0BETHESDA
IRS990ScheduleA/HospitalNameAndAddressGrp/CityNm1LOS ANGELES
IRS990ScheduleA/HospitalNameAndAddressGrp/StateAbbreviationCd0MD
IRS990ScheduleA/HospitalNameAndAddressGrp/StateAbbreviationCd1CA
IRS990ScheduleA/HospitalNameAndAddressGrp/SupportedOrganizationName/BusinessNameLine1Txt0WALTER REED NATIONAL MILITARY MEDICAL CENTER
IRS990ScheduleA/HospitalNameAndAddressGrp/SupportedOrganizationName/BusinessNameLine1Txt1UCLA FOUNDATION
IRS990ScheduleA/MedicalResearchOrganizationInd0X
IRS990/ScheduleBRequiredInd00
IRS990ScheduleD/EquipmentGrp/BookValueAmt0335932
IRS990ScheduleD/EquipmentGrp/DepreciationAmt04725161
IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt05061093
IRS990ScheduleD/FootnoteTextInd0X
IRS990ScheduleD/LeaseholdImprovementsGrp/BookValueAmt0849677
IRS990ScheduleD/LeaseholdImprovementsGrp/DepreciationAmt0709303
IRS990ScheduleD/LeaseholdImprovementsGrp/OtherCostOrOtherBasisAmt01558980
IRS990ScheduleD/OtherLandBuildingsGrp/BookValueAmt033690
IRS990ScheduleD/OtherLandBuildingsGrp/DepreciationAmt02076949
IRS990ScheduleD/OtherLandBuildingsGrp/OtherCostOrOtherBasisAmt02110639
IRS990ScheduleD/OtherSecuritiesGrp/BookValueAmt0563230
IRS990ScheduleD/OtherSecuritiesGrp/BookValueAmt12077000
IRS990ScheduleD/OtherSecuritiesGrp/BookValueAmt230901146
IRS990ScheduleD/OtherSecuritiesGrp/BookValueAmt34123416
IRS990ScheduleD/OtherSecuritiesGrp/BookValueAmt45552360
IRS990ScheduleD/OtherSecuritiesGrp/Desc0LIMITED PARTNERSHIPS
IRS990ScheduleD/OtherSecuritiesGrp/Desc1BIONESS INC.
IRS990ScheduleD/OtherSecuritiesGrp/Desc2MEDALLION THERAPEUTICS, INC.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2018 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$50,020,916
Liabilities
$656,801
Net assets
$49,364,115
Revenue
$431,624
Expenses
$13,081,377
Net income
-$12,649,753
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2025Facts available. Structured filing facts are available, but richer extracted sections are limited.$353$6.39$347$18.1$41.8$23.6
2024XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$373$6.67$366$44.1$31.8$12.3
2023Facts available. Structured filing facts are available, but richer extracted sections are limited.$345$6.00$339$31.1$22.8$8.23
2022Facts available. Structured filing facts are available, but richer extracted sections are limited.$374$2.65$372$129$18.1$110
2021Facts available. Structured filing facts are available, but richer extracted sections are limited.$307$2.73$305$226$22.4$204
2020Facts available. Structured filing facts are available, but richer extracted sections are limited.$59.1$11.5$47.6$2.31$13.9$11.5
2019Summary only. Only limited summary data is available for this year.$93.5$7.10$86.4$0.33$8.04$7.71
2018Detailed filing. Detailed filing data is available for this year.$50.0$0.66$49.4$0.43$13.1$12.6
2017XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$63.5$1.65$61.9$0.99$15.3$14.4
2016XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$82.1$8.16$74.0$4.54$17.3$12.7
2015Detailed filing. Detailed filing data is available for this year.$109$15.2$93.4$7.59$17.9$10.3
2014Detailed filing. Detailed filing data is available for this year.$115$11.2$104$19.6$24.2$4.56
2013Facts available. Structured filing facts are available, but richer extracted sections are limited.$122$15.4$106$22.3
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$127$14.9$112$24.7
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$149$15.5$134$22.0